Author: Stéphane Laurent Pierre Boutouyrie
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.19, Iss.1, 2005-01, pp. : 1-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ischaemic preconditioning: therapeutic implications for stroke?
By Pong Kevin
Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. :
Immunological Aspects of Ischaemic Stroke: Therapeutic Implications
By Stoll G.
CNS Drugs, Vol. 14, Iss. 3, 2000-09 ,pp. :
Disturbances of Calcium Homeostasis in Ischaemic Stroke: Therapeutic Implications
By Horn J.
CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. :
Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke
CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. :